IEQ Capital’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.1M | Buy |
112,251
+42,522
| +61% | +$5.34M | 0.09% | 176 |
|
|
2025
Q1 | $9.54M | Buy |
69,729
+10,195
| +17% | +$1.4M | 0.08% | 194 |
|
|
2024
Q4 | $9.1M | Buy |
59,534
+55,514
| +1,381% | +$8.49M | 0.09% | 145 |
|
|
2024
Q3 | $779K | Buy |
4,020
+278
| +7% | +$53.9K | 0.01% | 611 |
|
|
2024
Q2 | $867K | Buy |
3,742
+609
| +19% | +$141K | 0.01% | 509 |
|
|
2024
Q1 | $676K | Sell |
3,133
-1,150
| -27% | -$248K | 0.01% | 544 |
|
|
2023
Q4 | $1.11M | Sell |
4,283
-669
| -14% | -$173K | 0.02% | 406 |
|
|
2023
Q3 | $1.27M | Buy |
4,952
+827
| +20% | +$213K | 0.03% | 341 |
|
|
2023
Q2 | $1.17M | Buy |
4,125
+426
| +12% | +$121K | 0.02% | 360 |
|
|
2023
Q1 | $1.03M | Buy |
3,699
+127
| +4% | +$35.3K | 0.02% | 385 |
|
|
2022
Q4 | $989K | Buy |
3,572
+278
| +8% | +$77K | 0.03% | 369 |
|
|
2022
Q3 | $879K | Buy |
3,294
+1,051
| +47% | +$280K | 0.02% | 396 |
|
|
2022
Q2 | $457K | Buy |
2,243
+718
| +47% | +$146K | 0.01% | 497 |
|
|
2022
Q1 | $321K | Buy |
1,525
+522
| +52% | +$110K | 0.01% | 621 |
|
|
2021
Q4 | $241K | Sell |
1,003
-1,097
| -52% | -$264K | 0.01% | 646 |
|
|
2021
Q3 | $593K | Buy |
2,100
+514
| +32% | +$145K | 0.02% | 386 |
|
|
2021
Q2 | $549K | Buy |
1,586
+343
| +28% | +$119K | 0.02% | 349 |
|
|
2021
Q1 | $348K | Buy |
+1,243
| New | +$348K | 0.01% | 340 |
|
|
2020
Q4 | – | Sell |
-1,035
| Closed | -$294K | – | 240 |
|
|
2020
Q3 | $294K | Buy |
+1,035
| New | +$294K | 0.02% | 301 |
|
|
2020
Q2 | – | Sell |
-1,540
| Closed | -$488K | – | 328 |
|
|
2020
Q1 | $488K | Buy |
1,540
+505
| +49% | +$160K | 0.04% | 210 |
|
|
2019
Q4 | $308K | Buy |
+1,035
| New | +$308K | 0.03% | 308 |
|